Replies to post #251158 on Avid Bioservices Inc (CDMO)

[jq1234]

You looked at the wrong trial on clinicaltrials.gov. Here is the ph3 trial corresponding to the label insert result:

https://clinicaltrials.gov/ct2/show/NCT00844649?term=Abraxane+pancreatic&phase=2&rank=4

Look at inclusion criteria, it said clearly METASTATC which by definition is stage IV, similar to Bavituximab pancreatic trial population.

By the way, I don't consider my message rude, it is FACT. I consider your original reply to the poster who was right to compare Abaraxane pancreatic trial vs Bavituximab pancreatic trial rude by giving completely INCORRECT information while lecturing the other person about proper dd!